Please ensure Javascript is enabled for purposes of website accessibility

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

2 hours ago

‘Reservoir Dogs’ and ‘Kill Bill’ Actor Michael Madsen Dies at 67

3 hours ago

Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers

3 hours ago

Trump’s Sweeping Tax-Cut and Spending Bill Wins Congressional Approval

4 hours ago

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

7 hours ago

US Supreme Court to Decide Legality of Transgender School Sports Bans

8 hours ago

Nvidia Set to Become the World’s Most Valuable Company in History

8 hours ago

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

8 hours ago
NorCal Doctor: Not Everyone Needs COVID-19 Testing
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
April 10, 2020

Share

“We almost don’t need them for everybody,” Dr. Roberta Luskin-Hawk says of COVID-19 tests.
Her reasoning is explained below, but it also comes from a wealth of medical experience. She is an infectious disease specialist who worked with Dr. Anthony Fauci in Chicago during the AIDS epidemic. And she is the chief executive for St. Joseph Health in Eureka.
Her hospital just began a clinical trial for the antiviral drug remdesivir and has enrolled one patient so far.
GV Wire spoke to Luskin-Hawk via Zoom on Friday morning.

Q&A with Dr. Luskin-Hawk

GV Wire: Abbott Labs is producing about 50,000 COVID-19 test kits a day. Is it likely we’ll ever get enough test kits for everyone?

A test for someone with no symptoms is pretty meaningless because they could pick it up a week from now. But tests that are also in development are these antibody tests, which will be a blood test that will be simpler and easier to do. It will be for someone who has already been exposed and may have some immunity. So I think there will be combinations of testing, but the need to test for the virus itself is not something we need to do in every person.

Of all the clinical trials you could have joined, why remdesivir?

As an infectious disease doctor, I was intrigued by something that had specific antiviral activity. But I think the other compelling anecdote and it is strictly related to one case which is not sufficient to know how the drug works, but the first case report in the U.S., from Washington state was a man who was in ICU and was given remdesivir. This was reported in the New England Journal of Medicine … and the patient went on to do well.

What does remdesivir do?

These drugs interfere with (COVID-19) multiplying. This particular drug was developed in part to treat ebolavirus and then was studied in two other types of coronaviruses, what’s called SARS and MERS and both of them are kind of causes of the novel coronavirus we’re dealing with now.

How many patients are in the remdesivir trial?

We’ve enrolled one person so far. But enrollment across the country is so active these trials might be fully enrolled, even in a couple weeks, the way it’s going.

How has your patient responded?

I understand the patient is doing well but that’s probably all I can say. Because of privacy.

Do you have insights on some of the other vaccine trials?

I don’t have in-depth knowledge. I know there’s a vaccine that was developed in Israel that I understand may start trial as early as June. … There are many people trying to develop vaccines.
[covid-19-tracker]

Coronavirus Patients Rush to Join Studies of Gilead Drug

Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks.
Interest has been so great that the U.S. National Institutes of Health is expanding its study, which has nearly reached its initial goal of 440 patients. The drug’s maker, California-based Gilead Sciences, is quickly ramping up its own studies, too.
Remdesivir is given through an IV. It’s designed to interfere with an enzyme that reproduces viral genetic material.
Gilead supplied remdesivir for two studies in China. Results are expected by the end of April.

Cost to Produce the Medicines

According to Reuters, a study released Friday in the Journal of Virus Eradication, researchers, including Howard University chemist Joseph Fortunak, examined the cost of manufacturing medicines in recent or ongoing COVID-19 trials.
Using prices for active pharmaceutical ingredients to build estimates, they said Gilead Science’s experimental drug remdesivir, originally for Ebola, could be made for as little as $0.93 for a day’s supply.
Gilead said the figure does not “accurately reflect” manufacturing costs at scale, but it did not give those costs.
Gilead can produce 140,000 remdesivir treatment courses near-term, and 1 million-plus by December, it has projected.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

DON'T MISS

US Military Says 200 Marines Being Sent to Support ICE in Florida

DON'T MISS

Boeing Secures $2.8 Billion US Satellite Contract

DON'T MISS

Kaweah Health Names Its New Chief Nurse. She’s From Texas

DON'T MISS

Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County

DON'T MISS

Over 100 Former Senior Officials Warn Against Planned Staff Cuts at US State Department

DON'T MISS

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

DON'T MISS

‘Reservoir Dogs’ and ‘Kill Bill’ Actor Michael Madsen Dies at 67

DON'T MISS

Fresno Police Recover Some of the $40,000 in Fireworks Stolen From Bullard High Team

DON'T MISS

Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers

UP NEXT

After Record Democratic Speech, House Republicans Begin Final Vote on Trump Tax-Cut Bill

UP NEXT

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

UP NEXT

San Luis Obispo’s Madre Fire Grows to 35,000 Acres, More Evacuations Ordered

UP NEXT

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

UP NEXT

Wired Wednesday: Why Is State Lawmaker Taking Aim at Rooftop Solar?

UP NEXT

Poorest Americans Dealt Biggest Blow Under Senate Republican Tax Package

UP NEXT

Check Out Newest Downtown Mural. It’s a Spectacular Tribute to Fresno Artisans

UP NEXT

CHP Officer Dies in Line of Duty After Medical Emergency While on Patrol

UP NEXT

Downtown Housing Could Rise in Many California Cities, but Barriers Remain

UP NEXT

Bryan Kohberger to Plead Guilty to Murders of Four Idaho Students

Kaweah Health Names Its New Chief Nurse. She’s From Texas

1 hour ago

Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County

1 hour ago

Over 100 Former Senior Officials Warn Against Planned Staff Cuts at US State Department

2 hours ago

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

2 hours ago

‘Reservoir Dogs’ and ‘Kill Bill’ Actor Michael Madsen Dies at 67

3 hours ago

Fresno Police Recover Some of the $40,000 in Fireworks Stolen From Bullard High Team

3 hours ago

Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers

3 hours ago

Trump to Sign Bill on Friday at 5 p.m., White House Says

4 hours ago

Colombia President Recalls Ambassador to US

4 hours ago

Riverdale High School Coach Arrested for Allegedly Arranging to Meet Minor

4 hours ago

Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

As the drama unfolded Wednesday night into Thursday, Rep. David Valadao was one of the initial holdouts on voting for the “One Big Bea...

30 minutes ago

30 minutes ago

Valadao, Costa Spar on What Passage of Trump’s Bill Means for Medicaid Recipients

An ICE agent talks with migrants about their scheduled appointments with U.S. Immigration and Customs Enforcement (ICE) on Father’s Day, to learn about their immigration status, in Chicago, Illinois., U.S., June 15, 2025. (Reuters File)
53 minutes ago

US Military Says 200 Marines Being Sent to Support ICE in Florida

Boeing logo and miniature satellite model are seen in this illustration taken, March 10, 2025. (Reuters File)
1 hour ago

Boeing Secures $2.8 Billion US Satellite Contract

1 hour ago

Kaweah Health Names Its New Chief Nurse. She’s From Texas

Clovis Police are searching for Pathmani Goonawardena, 82, who went missing nearly three weeks ago and was last seen driving a white Volvo near Copper and Auberry, possibly en route to Coarsegold. (CHP)
1 hour ago

Clovis Police Say At-Risk Missing Woman Found Dead in Mariposa County

A general view of a U.S. State Department sign, on the day U.S. Secretary of State Marco Rubio meets with Hungarian Foreign Minister Peter Szijjarto, in Washington, D.C., U.S., March 4, 2025. (Reuters File)
2 hours ago

Over 100 Former Senior Officials Warn Against Planned Staff Cuts at US State Department

An electric vehicle charging location is shown from the view of a drone in Carlsbad, California, U.S., May 14, 2025. (Reuters File)
2 hours ago

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

Actor Michael Madsen arrives at the Hollywood Film Awards in Beverly Hills, California November 1, 2015. (Reuters File)
3 hours ago

‘Reservoir Dogs’ and ‘Kill Bill’ Actor Michael Madsen Dies at 67

Help continue the work that gets you the news that matters most.

Search

Send this to a friend